Weight Loss Sale

Catabolic Wasting References

Disease Prevention and Treatment, 5th edition

The references on this page correspond with the print version of Disease Prevention and Treatment, 5th edition. Since we continuously update the protocols online in response to new scientific developments, readers are encouraged to review the latest versions of the protocols.

  1. Castaneda, C., Grossi, L., Dwyer, J. Potential benefits of resistance exercise training on nutritional status in renal failure. J. Ren. Nutr. 1998 Jan; 8(1): 2-10.
  2. Fielding, RA. The role of progressive resistance training and nutrition in the preservation of lean body mass in the elderly. J. Am. Coll. Nutr. 1995 Dec; 14(6): 587-94.
  3. Beal, J.E. et al. Dronabinol as a treatment for anorexia with weight loss in patients with AIDS. J. Pain Sympt. Manage. 1995; 10: 89-97.
  4. Fairfield, W.P. et al. Effects of testosterone and exercise on muscle leanness in eugonadal men with AIDS wasting. J. Appl. Physiol. 2001; 90(6): 2166-71.
  5. Tisdale, M.J., Dhesi, J.K. Inhibition of weight loss by omega-3 fatty acids in an experimental cachexia model. Cancer Res. 1990 Aug 15; 50(16): 5022-6.
  6. Beck, S.A., Smith, K.L., Tisdale, M.J. Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res. 1991 Nov 15; 51(22): 6089-93.
  7. Tisdale, M.J. Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia. Nutrition 1996 Jan; 12(1, Suppl.): S31-S33.
  8. Khalfoun, B., Thibault, F., Watier, H., Bardos, P., Lebranchu, Y. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv. Exp. Med. Biol. 1997; 400(B): 589-97.
  9. De Caterina, R., Bernini, W., Carluccio, M.A., Liao, J.K., Libby, P. Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. J. Lipid Res. 1998 May; 39(5): 1062-70.
  10. De Caterina, R., Spiecker, M., Solaini, G., Basta, G., Bosetti, F., Libby, P., Liao, J. The inhibition of endothelial activation by unsaturated fatty acids. Lipids 1999; 34(Suppl.): S191-S194.
  11. Jeyarajah, D.R., Kielar, M., Penfield, J., Lu, C.Y. Docosahexaenoic acid, a component of fish oil, inhibits nitric oxide production in vitro. J. Surg. Res. 1999 May 15; 83(2): 147-50.
  12. Kelley, D.S., Taylor, P.C., Nelson, G.J., Schmidt, P.C., Ferretti, A., Erickson, K.L., Yu, R., Chandra, R.K., Mackey, B.E. Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids 1999 Apr; 34(4): 317-24.
  13. James, M.J., Gibson, R.A., Cleland, L.G. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr. 2000 Jan; 71(1, Suppl.): 343S-348S.
  14. Kremer, J.M. n-3 Fatty acid supplements in rheumatoid arthritis. Am. J. Clin. Nutr. 2000 Jan; 71(1, Suppl.): 349S-351S.
  15. Watanabe, S., Katagiri, K., Onozaki, K., Hata, N., Misawa, Y., Hamazaki, T., Okuyama, H. Dietary docosahexaenoic acid but not eicosapentaenoic acid suppresses lipopolysaccharide-induced interleukin-1 beta mRNA induction in mouse spleen leukocytes. Prostaglandins Leukot. Essent. Fatty Acids 2000 Mar; 62(3): 147-52.
  16. Yano, M., Kishida, E., Iwasaki, M., Kojo, S., Masuzawa, Y. Docosahexaenoic acid and vitamin E can reduce human monocytic U937 cell apoptosis induced by tumor necrosis factor. J. Nutr. 2000 May; 130(5): 1095-1101.
  17. Das, U.N. Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how? Prostaglandins Leukot. Essent. Fatty Acids 2000 Dec; 63(6): 351-62; erratum, Prostaglandins Leukot. Essent. Fatty Acids 2001 Jan; 64(1): 74.
  18. Tepaske, R., Velthuis, H., Oudemans-van Straaten, H.M., Heisterkamp, S.H., van Deventer, S.J., Ince, C., Eysman, L., Kesecioglu, J. Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial. Lancet 2001; 358(9283): 696-701.
  19. Purasiri, P., Murray, A., Richardson, S., Heys, S.D., Horrobin, D., Eremin, O. Modulation of cytokine production in vivo by dietary essential fatty acids in patients with colorectal cancer. Clin. Sci. 1994 Dec; 87(6): 711-7.
  20. Mancuso, P., Whelan, J., DeMichele, S.J., Snider, C.C., Guszcza, J.A., Karlstad, M.D. Dietary fish oil and fish and borage oil suppress intrapulmonary proinflammatory eicosanoid biosynthesis and attenuate pulmonary neutrophil accumulation in endotoxic rats. Crit. Care Med. 1997 Jul; 25(7): 1198-1206.
  21. Dirks, J., van Aswegen, C.H., du Plessis, D.J. Cytokine levels affected by gamma-linolenic acid. Prostaglandins Leukot. Essent. Fatty Acids 1998 Oct; 59(4): 273-7.
  22. DeLuca, P., Rossetti, R.G., Alavian, C., Karim, P., Zurier, R.B. Effects of gammalinolenic acid on interleukin-1 beta and tumor necrosis factor-alpha secretion by stimulated human peripheral blood monocytes: studies in vitro and in vivo. J. Investig. Med. 1999 May; 47(5): 246-50.
  23. Millward, D.J., Jepson, M.M., Omer, A. Muscle glutamine concentration and protein turnover in vivo in malnutrition and endotoxemia. Metabolism 1989 Aug; 38(8, Suppl. 1): 6-13.
  24. Castell, L.M., Bevan, S.J., Calder, P., Newsholme, E.A. The role of glutamine in the immune system and in intestinal function in catabolic states. Amino Acids 1994; 7(3): 231-43.
  25. Ziegler, T.R., Szeszycki, E.E., Estivariz, C.F., Puckett, A.B., Leader, L.M. Glutamine: from basic science to clinical applications. Nutrition 1996 Nov-Dec; 12(11-12, Suppl.): S68-S70.
  26. Furst, P., Albers, S., Stehle, P. Evidence for a nutritional need for glutamine in catabolic patients. Kidney Int. Suppl. 1989 Nov; 27: S287-S292.
  27. Campos, F.G., Waitzberg, D.L., Logulo, A.F., Mucerino, D.R., Habr-Gama, A. The role of glutamine in nutrition in clinical practice. Arq. Gastroenterol. 1996 Apr-Jun; 33(2): 86-92.
  28. Griffiths, R.D. Outcome of critically ill patients after supplementation with glutamine. Nutrition 1997; 13(7-8): 752-4.
  29. Sacks, G.S. Glutamine supplementation in catabolic patients. Ann. Pharmacother. 1999 Mar; 33(3): 348-54.
  30. Balzola, F.A., Boggio-Bertinet, D. The metabolic role of glutamine. Minerva Gastroenterol. Dietol. 1996 Mar; 42(1): 17-26.
  31. Roth, E., Spittler, A., Oehler, R. Glutamine: effects on the immune system, protein metabolism and intestinal function. Wien. Klin. Wochenschr. 1996; 108(21): 669-76.
  32. Zhou, X., Thompson, J.R. Regulation of protein turnover by glutamine in heat-shocked skeletal myotubes. Biochim. Biophys. Acta 1997 Jun 27; 1357(2): 234-42.
  33. Hankard, R.G., Haymond, M.W., Darmaun, D. Effect of glutamine on leucine metabolism in humans. Am. J. Physiol. 1996 Oct; 271(4, Pt. 1): E748-54.
  34. Becker, R.M., Wu, G., Galanko, J.A., Chen, W., Maynor, A.R., Bose, C.L., Rhoads, J.M. Reduced serum amino acid concentrations in infants with necrotizing enterocolitis. J. Pediatr. 2000 Dec; 137(6): 785-93.
  35. Slotwinski, R., Pertkiewicz, M., Lech, G., Szczygiel, B. Cellular immunity changes after total parenteral nutrition enriched with glutamine in patients with sepsis and malnutrition. Pol. Merkuriusz Lek. 2000 Jun; 8(48): 405-8 (in Polish).
  36. Bounous, G., Baruchel, S., Falutz, J., Gold, P. Whey proteins as a food supplement in HIV-seropositive individuals. Clin. Invest. Med. 1993 Jun; 16(3): 204-9.
  37. McIntosh, G.H., Regester, G.O., Le Leu, R.K., Royle, P.J., Smithers, G.W. Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats. J. Nutr. 1995 Apr; 125(4): 809-16.
  38. Kennedy, R.S., Konok, G.P., Bounous, G., Baruchel, S., Lee, T.D. The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma: a phase I-II clinical study. Anticancer Res. 1995 Nov-Dec; 15(6B): 2643-9.
  39. Baruchel, S., Viau, G. In vitro selective modulation of cellular glutathione by a humanized native milk protein isolate in normal cells and rat mammary carcinoma model. Anticancer Res. 1996 May-Jun; 16(3A): 1095-9.
  40. Zhou MS, Kosaka H, Tian RX, et al. L-Arginine improves endothelial function in renal artery of hypertensive Dahl rats. J Hypertens. 2001;19:421-429.
  41. Brose A, Parise G, Tarnopolsky MA. Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults. J Gerontol A Biol Sci Med Sci. 2003 Jan;58(1):11-9.
  42. Gotshalk LA, Volek JS, Staron RS, et al. Creatine supplementation improves muscular performance in older men. Med Sci Sports Exerc. 2002 Mar;34(3):537-43.
  43. Chrusch MJ, Chilibeck PD, Chad KE, Davison KS, Burke DG. Creatine supplementation combined with resistance training in older men. Med Sci Sports Exerc. 2001 Dec;33(12):2111-7.
  44. Montero-Odasso M, Duque G. Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Mol Aspects Med. 2005 Jun;26(3):203-19.
  45. Miller, C.C., Park, Y., Pariza, M.W., Cook, M.E. Feeding conjugated linoleic acid to animals partially overcomes catabolic responses due to endotoxin injection. Biochem. Biophys. Res. Commun. 1994 Feb 15; 198(3): 1107-12.
  46. May PE et al. Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine. Am J Surg. 2002 Apr;183(4):471-9.